A New Era of Growth for DSM-Firmenich
In a significant milestone for the company, DSM-Firmenich has announced a substantial increase in its financial results for 2024. This impressive performance is a direct result of the company’s strategic plan, which has been expertly executed to establish DSM-Firmenich as a leading innovation-focused consumer company in the nutrition, health, and beauty sectors.
The company’s strong organic sales growth and improved cash flow have been key drivers of this success. This achievement is a testament to the hard work and dedication of the DSM-Firmenich team, who have worked tirelessly to bring the company’s vision to life.
A Commitment to Sustainability
In addition to its impressive financial performance, DSM-Firmenich has also made significant strides in its commitment to sustainability. The company has set ambitious climate targets, which have been externally validated by the Science-Based Targets initiative. This recognition is a testament to DSM-Firmenich’s dedication to reducing its environmental impact and promoting a more sustainable future.
A Bright Future Ahead
As DSM-Firmenich looks to the future, the company is proposing a stable dividend of €2.50. This move demonstrates the company’s confidence in its financial performance and its commitment to rewarding shareholders. Additionally, DSM-Firmenich plans to launch a €1 billion share buyback program, which will further enhance shareholder value.
Looking ahead to 2025, DSM-Firmenich is expecting to achieve adjusted EBITDA of at least €2.4 billion. This ambitious target is a clear indication of the company’s continued commitment to growth and innovation.
Key Highlights
- Strong organic sales growth and improved cash flow drive financial performance
- Ambitious climate targets externally validated by the Science-Based Targets initiative
- Proposed stable dividend of €2.50
- €1 billion share buyback program to enhance shareholder value
- Target of adjusted EBITDA of at least €2.4 billion in 2025